CollPlant Biotechnologies (CLGN) Share-based Compensation (2018 - 2025)
CollPlant Biotechnologies (CLGN) posted Share-based Compensation of -$18000.0 for Q4 2025, down 106.38% on a QoQ basis from $282000.0 in Q3 2025, and down 104.25% year-over-year from $424000.0 in Q4 2024.
CollPlant Biotechnologies (CLGN) Share-based Compensation (2018 - 2025) Analysis & Trends
CollPlant Biotechnologies' Share-based Compensation history runs 8 years deep, the most recent figure standing at -$18000.0 for Q4 2025.
- Quarterly Share-based Compensation fell 104.25% year-over-year to -$18000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $1.0 million (down 39.44% YoY) and the FY2025 annual result came in at $999000.0, down 41.88% from the prior year.
- Share-based Compensation was -$18000.0 for Q4 2025 at CollPlant Biotechnologies, down from $282000.0 in the prior quarter.
- Across five years, Share-based Compensation topped out at $2.9 million in Q4 2021 and bottomed at -$368000.0 in Q3 2021.
- A 5-year average of $523789.5 and a median of $469000.0 in 2021 frame the typical range for Share-based Compensation.
- Annual changes were most pronounced in 2021 — Share-based Compensation slumped 198.66% — and 2022, when it jumped 284.78%.
- CollPlant Biotechnologies' Share-based Compensation stood at $2.9 million in 2021, then slumped by 84.96% to $439000.0 in 2022, then increased by 28.47% to $564000.0 in 2023, then decreased by 24.82% to $424000.0 in 2024, then plunged by 104.25% to -$18000.0 in 2025.
- Business Quant data shows CLGN's Share-based Compensation at -$18000.0 in Q4 2025, $282000.0 in Q3 2025, and $353000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Share-based Compensation (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | 6.39 Mn |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 305,000.00 |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 9.26 Mn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 166.40 Mn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 257.40 Mn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 87.30 Mn |
| 10 | CollPlant Biotechnologies | 4.63 Mn | 4.63 Mn | -243,000.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -18,000.00 |
| Dec 31, 2025 | -18,000.00 |
| Sep 30, 2025 | 282,000.00 |
| Sep 30, 2025 | 282,000.00 |
| Jun 30, 2025 | 353,000.00 |
| Jun 30, 2025 | 353,000.00 |
| Dec 31, 2024 | 424,000.00 |
| Dec 31, 2024 | 424,000.00 |
| Sep 30, 2024 | 515,000.00 |
| Sep 30, 2024 | 515,000.00 |
| Jun 30, 2024 | 490,000.00 |
| Jun 30, 2024 | 490,000.00 |
| Mar 31, 2024 | 290,000.00 |
| Mar 31, 2024 | 290,000.00 |
| Dec 31, 2023 | 564,000.00 |
| Dec 31, 2023 | 564,000.00 |
| Sep 30, 2023 | 521,000.00 |
| Sep 30, 2023 | 521,000.00 |
| Jun 30, 2023 | 338,000.00 |
| Jun 30, 2023 | 338,000.00 |